Study of anesthesiology possible through support of Amsterdam UMC spin-off
October 21, 2021Oxygen is of vital importance. In critical situations, the management of oxygenation is difficult. Many interventions during and after surgery and in intensive care are aimed at maintaining oxygen levels in organ cells. Until now, only indirect information about this has been available. As a result, what is the best treatment for the individual patient is often controversial. With Photonics
Healthcare’s COMET system, it is now possible to measure oxygen availability directly in cells that require oxygen. In the AIMED COMET study, anesthesiologists are investigating how to improve cellular oxygen availability in the skin with common interventions. Sufficient oxygenation at the cellular level is an important step to prevent complications such as wound infections, and possibly organ failure. Both locations (AMC and VUmc) of Amsterdam UMC are participating in the AIMED COMET study led by Prof. Dr. Markus Hollmann and made possible in part by support from spin-off Photonics Healthcare, which is bringing an invention from Amsterdam UMC and ErasmusMC into clinical practice.
More news
Contribute to Amsterdam’s Future: test your innovation at SAIL and the Amsterdam Marathon
Are you looking for a testing ground for your innovation? SAIL and the Amsterdam Marathon present an excellent opportunity to test your ideas. These major events attract millions of visitors and come with sustainability, accessibility, and logistical challenges that need fresh solutions. The In Residence Events program allows you to test your innovation during these […]
News
Tackling learning difficulties in Academic Workplace
The Academic Workplace Rudolf Berlin Center (AW RBC) aims to make a meaningful contribution by supporting young people with learning disabilities through enhanced education and care.
News
VU researchers develop research equipment to identify contaminants in water
Water, comprising over 70% of our planet, is the source of all life. The presence of emerging contaminants in our water, including pharmaceuticals, pose serious health and environmental risks, such as DNA damage, reproductive issues, and cancer. New equipment to detect these contaminants developed by VU researchers has been sold to other research groups all over the world. Now the researchers are taking the next step, together with IXA, to expand sales to water companies worldwide as well as other applications such as food and drug discovery research.
News